Posts Tagged: "Barks and Bites"

Other Barks & Bites for Friday, December 20: Inventor Rights Act Introduced, House Passes the USMCA, and Copyright Office Appoints Acting Register

This week in Other Barks & Bites: the Inventor Rights Act is introduced into the House of Representatives; House overwhelmingly passes USMCA; major tech companies lobby the European Commission to address holdups in patent licensing; Cox Communications is hit with a billion-dollar verdict in a major copyright case; the USPTO issues a second extension to the effective date of its mandatory electronic trademark filing rule; the Copyright Office appoints Maria Strong as Acting Register of Copyrights; the EU’s highest court rules that e-book resales aren’t protected by copyright exhaustion principles; Senator Tillis announces series of DMCA modernization hearings through 2020; and Bristol-Myers Squibb wins $752 million in cancer treatment patent case against Gilead Sciences.

Other Barks & Bites for Friday, December 13: U.S. and China Move Towards Trade Deal, Register Temple Leaves Copyright Office, and Tillis Sends Letters on Copyright Issues

This week in Other Barks & Bites: Senator Thom Tillis (R-NC) gets active on copyright matters, signing a trio of letters related to piracy and Copyright Office matters; Karyn Temple leaves her post as Register of Copyrights at the Copyright Office; the Supreme Court decides Peters v. NantKwest, finding that the USPTO can’t recover legal personnel fees in district court proceedings; Facebook shares drop due to a potential Federal Trade Commission injunction against messaging services integration; the Federal Circuit denies a rehearing petition on Capital One’s antitrust claims against Intellectual Ventures; House Democrats allow the USCMA free trade agreement to move towards ratification; news reports indicate that the U.S. and China have a limited trade deal in place; and the EU rules that marijuana-related trademarks are contrary to public policy. 

Other Barks & Bites, Friday, November 15: SCOTUS to Hear Booking.com Trademark Case, AG Barr Backs FCC Plan Against Huawei and ZTE, Copyright Office Eliminates Physical Material Submission Options

This week in Other Barks & Bites: the Federal Circuit strikes down a district court’s finding of design patent infringement on summary judgment; the USPTO advises trademark attorneys to monitor filings to prevent against the unauthorized use of their names; the U.S. Copyright Office issues final rules eliminating options for physical material submissions for newspaper and serial registrations; the U.S. Supreme Court will take up Booking.com’s appeal of the rejection of its trademark application by the USPTO; AG Barr supports the FCC’s plan to restrict Huawei and ZTE equipment purchases through the Universal Service Fund; Nirvana’s copyright case against Marc Jacobs moves past a motion to dismiss; Biogen loses $3 billion in market value after PTAB hearing; and Amazon seeks an injunction against a patent owner asserting infringement claims against Amazon Fire product retailers.

Other Barks & Bites, Friday, September 27: CAFC Partially Vacates PTAB Decision, Colarulli Appointed to Head LESI, and Copyright Office Seeks Comments on Music Modernization Act

This week in Other Barks & Bites: the Federal Circuit issued a precedential decision reversing the PTAB regarding proper primary reference and CBM review findings; USPTO Director Iancu told IPO Annual Meeting attendees that subject matter eligibility guidelines are working; an EPO-EUIPO report shows IP-intensive industries contribute nearly half of EU GDP; the producers of the Broadway musical Hamilton have filed a motion to dismiss copyright claims filed in connection with a museum exhibit; eBay CEO Devin Wenig stepped down; the Ninth Circuit heard oral arguments in the en banc rehearing of the “Stairway to Heaven” copyright case; the U.S. Copyright Office is seeking public comments regarding the blanket licensing structure under the Music Modernization Act; and Sandoz has moved forward with a PTAB challenge on patent claims covering AbbVie’s Imbruvica.

Other Barks & Bites, Friday, August 23: POP Issues Key Ruling, Gilead Challenges PrEP Patents, Qualcomm and LG Enter Licensing Agreement

This week in Other Barks & Bites: the USPTO’s Precedential Opinion Panel delivers a key ruling for inventors; the Second Circuit rules that a series of six film scores weren’t works for hire under U.S. or Italian law; Gilead files for inter partes review of patents owned by the U.S. government covering PrEP treatments; Qualcomm and LG Electronics enter into a five-year patent licensing agreement for wireless technologies; Taiwan begins implementing a patent linkage system for drug approvals; HP appoints a new CEO; Eminem music publishing firm files a copyright infringement suit against Spotify; and the DOJ and the Copyright Office support Led Zeppelin in the “Stairway to Heaven” copyright case.

Other Barks & Bites for Friday, April 26: World IP Day Celebrations, Special 301 Report, and Amazon Helps Identify Patent Infringers

This week in Other Barks & Bites, governments and intellectual property offices around the world celebrate World IP Day; the U.S. Trade Representative releases its most recent Notorious Markets List; TiVo subsidiary Rovi files another patent suit against licensing holdout Comcast; Amazon ramps up program for connecting sellers with lawyers for patent infringement issues; the USPTO seeks public comments on gathering data for SUCCESS Act study; music industry groups submit letter to Copyright Office regarding Mechanical Licensing Collective membership; and weak China data center sales sends Intel stock tumbling by 7.5 percent.

Other Barks & Bites for Friday, February 8

This week in Other Barks & Bites: the Federal Circuit affirms a Section 101 invalidation of patent claims in favor of Mayo Collaborative Services; Apple wins an order to limit damages in Qualcomm patent case; Google frets over proposed European Union copyright rules; India proposes jail time for film piracy; patent validity challenges drag down the stock of a major pharmaceutical firm; and a snag in the U.S.-China trade talks throws Wall Street for a loop.